Investigation announced for Investors in Charles River Laboratories International, Inc. (NYSE: CRL) concerning possible Violations of Securities Laws

An investigation was announced over potential securities laws violations by Charles River Laboratories International, Inc. in connection with certain financial statements.

Investors who purchased shares of Charles River Laboratories International, Inc. (NYSE: CRL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Charles River Laboratories International, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Wilmington, MA based Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. reported that its annual Total Revenue rose from over $3.54 billion in 2021 to over $3.97 billion in 2022, and that its Net Income increased from $390.98 million in 2021 to$650.97 million in 2022.

On February 22, 2023, Charles River Laboratories International, Inc. disclosed that it received a subpoena from the Justice Department relating to an ongoing investigation into the supply chain and illegal importation of nonhuman primates for research. The Company has voluntarily suspended shipments of primates from Cambodia. The Company also warned that the decision to suspend shipments will negatively impact its earnings this year and will reduce revenue growth by 200 basis points to 400 basis points.

Shares of Charles River Laboratories International, Inc. (NYSE: CRL) declined from $262 per share on February 08, 2023, to $207.01 per share on February 22, 2023.

Those who purchased shares of Charles River Laboratories International, Inc. (NYSE: CRL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.